President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...

It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...

While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily toward branded drugmakers, generic medicines and the companies that ...

As Bharat Biotech, Syngene, and others enter next-gen medicine manufacturing, experts see a future where advanced cancer and ...

Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy ...

Far too many seniors face an impossible choice: pay for prescription drugs, or purchase other necessities. Roughly one in ...